
Figure 1. Dose dependent stimulation of intracellular cAMP accumulation upon treatment with lithocholic acid (LCA) in CHO-K1/GPBAR1 cells. d2 acceptor fluorophore-labeled cAMP (Cat. No. 62AM4PEB; Revvity) and intracellular cAMP in CHO-K1/GPBAR1 cells competitively bind with Europium Cryptate-labeled anti-cAMP antibody. The FRET signal decreases as the intracellular cAMP concentration rises and was measured by plate reader (Pherastar, BMG). The EC50 of LCA on CHO-K1/GPBAR1 cells was 3.34 μM.

Figure 1. Dose dependent stimulation of intracellular cAMP accumulation upon treatment with lithocholic acid (LCA) in CHO-K1/GPBAR1 cells. d2 acceptor fluorophore-labeled cAMP (Cat. No. 62AM4PEB; Revvity) and intracellular cAMP in CHO-K1/GPBAR1 cells competitively bind with Europium Cryptate-labeled anti-cAMP antibody. The FRET signal decreases as the intracellular cAMP concentration rises and was measured by plate reader (Pherastar, BMG). The EC50 of LCA on CHO-K1/GPBAR1 cells was 3.34 μM.
CHO-K1/GPBAR1 Stable Cell Line
M00432 | |
|
|
¥1,661,121.00 | |
|
|
|
|
Ask us a question |